AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics (Babson), a transformative medical technology company, is improving the way the public receives diagnostic blood testing. According to the CDC, 70% ...
Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results